![](/img/cover-not-exists.png)
A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors
Thierry Lesimple, Julien Edeline, Timothy J. Carrothers, Frédérique Cvitkovic, Borje Darpo, Jean-Pierre Delord, Hervé Léna, Nicolas Penel, Geoff J. Edwards, Kenneth Law, Jantien Wanders, Allan KristenVolume:
31
Language:
english
DOI:
10.1007/s10637-012-9893-8
Date:
August, 2013
File:
PDF, 391 KB
english, 2013